SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:uu-319611"
 

Sökning: onr:"swepub:oai:DiVA.org:uu-319611" > ENETS Consensus Gui...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00005599naa a2200637 4500
001oai:DiVA.org:uu-319611
003SwePub
008170406s2017 | |||||||||||000 ||eng|
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3196112 URI
0247 a https://doi.org/10.1159/0004718792 DOI
040 a (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
1001 a Sundin, Anders,d 1954-u Uppsala universitet,Radiologi4 aut0 (Swepub:uu)anderssu
2451 0a ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors :b Radiological, Nuclear Medicine & Hybrid Imaging.
264 c 2017-03-30
264 1b S. Karger AG,c 2017
338 a print2 rdacarrier
520 a Contrast-enhanced computed tomography (CT) of the neckthorax-abdomen and pelvis, including 3-phase examination of the liver, constitutes the basic imaging for primary neuroendocrine tumor (NET) diagnosis, staging, surveillance, and therapy monitoring. CT characterization of lymph nodes is difficult because of inadequate size criteria (short axis diameter), and bone metastases are often missed. Contrast-enhanced magnetic resonance imaging (MRI) including diffusion-weighted imaging is preferred for the examination of the liver, pancreas, brain and bone. MRI may miss small lung metastases. MRI is less well suited than CT for the examination of extended body areas because of the longer examination procedure. Ultrasonography (US) frequently provides the initial diagnosis of liver metastases and contrast-enhanced US is excellent to characterize liver lesions that remain equivocal on CT/MRI. US is the method of choice to guide the biopsy needle for the histopathological NET diagnosis. US cannot visualize thoracic NET lesions for which CTguided biopsy therefore is used. Endocopic US is the most sensitive method to diagnose pancreatic NETs, and additionally allows for biopsy. Intraoperative US facilitates lesion detection in the pancreas and liver. Somatostatin receptor imaging should be a part of the tumor staging, preoperative imaging and restaging, for which 68 Ga-DOTA-somatostatin analog PET/CT is recommended, which is vastly superior to somatostatin receptor scintigraphy, and facilitates the diagnosis of most types of NET lesions, for example lymph node metastases, bone metastases, liver metastases, peritoneal lesions, and primary small intestinal NETs. (18)FDG-PET/CT is better suited for G3 and high G2 NETs, which generally have higher glucose metabolism and less somatostatin receptor expression than low-grade NETs, and additionally provides prognostic information.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Endokrinologi och diabetes0 (SwePub)302052 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Endocrinology and Diabetes0 (SwePub)302052 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Neurovetenskaper0 (SwePub)301052 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Neurosciences0 (SwePub)301052 hsv//eng
653 a Neuroendocrine tumor
653 a Computed tomography
653 a Magnetic resonance imaging
653 a Ultrasound
653 a Positron emission tomography
653 a Scintigraphy
653 a Single photon emission computed tomography
653 a Somatostatin receptor imaging
7001 a Arnold, Rudolfu Philipps Univ, Dept Gastroenterol & Endocrino4 aut
7001 a Baudin, Ericu Gustave Roussy Canc Campus, Dept Endocrine Oncol & Nucl Med4 aut
7001 a Cwikla, Jaroslaw Bu Univ Warmia & Mazury, Fac Med Sci, Dept Radiol4 aut
7001 a Eriksson, Barbrou Uppsala universitet,Endokrin tumörbiologi4 aut0 (Swepub:uu)barberik
7001 a Fanti, Stefanou Univ Bologna, Policlin S Orsola, Dept Nucl Med4 aut
7001 a Fazio, Nicolau European Inst Oncol, Unit Gastrointestinal Med Oncol & Neuroendocrine4 aut
7001 a Giammarile, Francescou Univ Lyon, Hosp Civils Lyon, Nucl Med Dept4 aut
7001 a Hicks, Rodney Ju Peter MacCallum Canc Ctr, Canc Imaging4 aut
7001 a Kjaer, Andreasu Rigshosp, Dept Clin Physiol Nucl Med & PET; Rigshosp, Cluster Mol Imaging; Univ Copenhagen4 aut
7001 a Krenning, Ericu Erasmus MC, Dept Nucl Med4 aut
7001 a Kwekkeboom, Diku Erasmus MC, Dept Nucl Med4 aut
7001 a Lombard-Bohas, Catherineu Hop Edouard Herriot, Hosp Civils Lyon, Inst Canc4 aut
7001 a O'Connor, Juan Mu Gastroenterol Hosp B Udaondo, Alexander Fleming Inst4 aut
7001 a O'Toole, Dermotu Univ Dublin, St Jamess Hosp, Trinity Coll Dublin; St Vincents Univ Hosp4 aut
7001 a Rockall, Andreau Royal Marsden NHS Fdn Trust, Dept Radiol; Imperial Coll London4 aut
7001 a Wiedenmann, Bertramu Charite Univ Med Berlin, Campus Charite Mitte, Dept Gastroenterol & Hepatol; Charite Univ Med Berlin, Campus Virchow Klinikum4 aut
7001 a Valle, Juan Wu Univ Manchester, Christie NHS Fdn Trust, Inst Canc Sci4 aut
7001 a Vullierme, Marie-Pierreu Hop Beaujon, Serv Gastroenterol4 aut
7102 a Uppsala universitetb Radiologi4 org
7730 t Neuroendocrinologyd : S. Karger AGg 105:3, s. 212-244q 105:3<212-244x 0028-3835x 1423-0194
8564 u https://www.research.manchester.ac.uk/portal/files/53805969/2017_Sundin_et_al_Neuroendocrinology_Standards_of_Care_Imaging.pdf
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-319611
8564 8u https://doi.org/10.1159/000471879

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy